info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Acute Gout Flare Therapeutics Market By Drug Class (NSAIDs, Colchicine, Corticosteroids, Biologic / IL-1-Targeted Agents, Other Acute Agents); By Route of Administration (Oral, Injectable); By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

Acute Gout Flare Therapeutics Market

Research Description | Market Intelligence, Competitive Dynamics and 2026 Pipeline Update

Prepared by Strategic Market Research  |  Last substantively reviewed: 25 Augus... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

Acute Coronary Syndrome Market By Syndrome Type (NSTEMI, STEMI, Unstable Angina); By Treatment Modality (Medications, Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting); By End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

What Is the Acute Coronary Syndrome Market Size and What Is Shaping Its Clinical Landscape?  – (Updated On: 26-Aug-2026)

The Global Acute Coronary Syndrome Market was valued at USD 10.25 billion in 2025 and is projected to reach USD 16.03 billion by 20... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market By Drug Class (Oxazolidinones, Lipoglycopeptides, Lipopeptides, Beta-lactams & Cephalosporins, Others); By Route of Administration (Intravenous, Oral, Long-Acting Injectable); By Infection Type (Cellulitis, Wounds, Abscesses, Trauma); By End User (Hospitals, ASCs, Outpatient Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Bacterial Skin and Skin Structure Infections Market is projected to expand steadily, valued at approximately USD 5.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Acid Sphingomyelinase Deficiency (ASMD) Market By Product Type (Enzyme Replacement Therapy, Gene Therapy Candidates, Supportive Care); By Application (Type A – Infantile Neurovisceral, Type B – Chronic Visceral, Type A/B Intermediate); By End User (Specialty & Tertiary Hospitals, Academic & Research Institutes, Home Infusion & Specialty Pharmacies, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acid Sphingomyelinase Deficiency Market will witness a strong growth trajectory, valued at USD 450 million in 2024 and projected to reach approximately Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Achondroplasia Market By Therapy Type (CNP Analogs, FGFR Inhibitors, Adjunctive & Supportive Care); By Patient Age Group (Pediatrics, Adults); By Route of Administration (Subcutaneous Injections, Oral Therapies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Achondroplasia Market will expand steadily between 2024 and 2030, with the market estimated at USD 1.1 billion in 2024 and projected to reach around USD 2.4 billio... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

LAG-3 Targeting Therapy Market By Therapy Type (Monotherapy, Combination Therapy); By Indication (Melanoma, Non-Small Cell Lung Cancer, Triple-Negative Breast Cancer, Head & Neck Squamous Cell Carcinoma, Other Solid Tumors, Hematologic Malignancies); By End User (Hospitals, Specialty Cancer Centers, Academic Research Institutes, Clinical Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global LAG-3 Targeting Therapy Market valued at USD 1.37 billion in 2024 and projected to exceed USD 5.1 billion by 2030 at 24.1% CAGR, highlighting tumo... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

PRMT5 Targeted Therapies Market By Drug Type (Small Molecule Inhibitors, Allosteric Inhibitors, Protein Degraders); By Application (NSCLC, Glioblastoma, Pancreatic Cancer, Mantle Cell Lymphoma, AML, MDS); By Route of Administration (Oral, Intravenous); By End User (Academic Cancer Centers, Oncology Clinics, Community Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PRMT5 Targeted Therapies Market is poised to expand at a robust CAGR of 28.4%, valued at approximately USD 412 million in 2024, and proje... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

CD39 Targeted Therapies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, Small-Molecule Inhibitors); By Cancer Indication (Non-Small Cell Lung Cancer, Pancreatic Cancer, Gastrointestinal Stromal Tumors, Desmoid Tumors, Other Solid Tumors); By Treatment Approach (Monotherapy, Combination Immunotherapy, Combination Chemotherapy, Perioperative Therapy); By End User (Hospitals, Specialty Cancer Centers, Research Institutes, Clinical Trial Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

CD39 Targeted Therapies Market: Biomarker Validation and Randomized Evidence Define the Commercial Race

The Global CD39 Targeted Therapies Market is estimated to reach USD 498.54 million in 2025 and is projected to grow... Read More

Published Date: JUL-2026 | No Of Pages:157 | $ 4485

Biotherapeutics Market By Product Type (Monoclonal Antibodies, Recombinant Proteins, Cell Therapy Products, Gene Therapies, Vaccines); By Application (Oncology, Autoimmune Diseases, Rare Genetic Disorders, Infectious Diseases, Neurological Disorders); By Route of Administration (Intravenous, Subcutaneous, Oral & Others); By End User (Academic & Specialty Hospitals, General Hospitals, Infusion Clinics, Specialty Pharmacies & Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biotherapeutics Market is projected to grow from USD 356.7 billion in 2024 to nearly USD 587.2 billion by 2030 at a steady 8.6% CAGR, driven by advances i... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Hormonal Contraceptives Market By Product Type (Combined Hormonal Contraceptives, Progestin-Only Contraceptives); By Route of Administration (Oral, Intrauterine, Subdermal, Injectable, Transdermal, Vaginal); By Distribution Channel (Hospital & Institutional Channels, Retail & Community Pharmacies, Online Pharmacies & Direct-to-Consumer Channels); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Hormonal Contraceptives Market - Market Size, Revenue Architecture, Product Mix, Access Channels, Competitive Positioning and 2032 Outlook – (Updated On: 31-Aug-2026)

What Is the Hormonal Contraceptives Market Size and How Is the Product Landscape Chang... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Tumor Infiltrating Lymphocytes (TILs) Market By Therapy Type (Autologous TILs, Genetically Modified TILs); By Indication (Melanoma, NSCLC, Cervical Cancer, Head & Neck Cancer, Others); By Manufacturing Model (Centralized, Decentralized); By End User (Academic Centers, Oncology Hospitals, Cell Therapy Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tumor Infiltrating Lymphocytes (TILs) Market is projected to reach USD 1.26 billion in 2024 and grow to USD 3.47 billion by 2030 at a robust 18.5% CAGR, d... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Venous Thromboembolism (VTE) Treatment Market By Product Type (Anticoagulants, Thrombolytic Agents, Mechanical Thrombectomy Devices, Vena Cava Filters); By Route of Administration (Oral, Injectable, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Venous Thromboembolism (VTE) Treatment Market is projected to grow at a steady 6.5% CAGR, rising from USD 10.8 billion in 2024 to nearly USD 16.5 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Mitochondrial Disease Therapies Market By Therapy Type (Small Molecules, Gene Therapy, Enzyme Replacement, Others); By Route of Administration (Oral, Injectable/Intravenous, Others); By End User (Hospitals, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mitochondrial Disease Therapies Market will expand steadily at an CAGR of 9.1%, valued at USD 1.1 billion in 2024, and projected to reach USD 2.0 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Pulmonary Embolism Therapeutics Market By Drug Class (DOACs, LMWH, Unfractionated Heparin, Vitamin K Antagonists, Thrombolytics); By Route of Administration (Oral, Injectable); By Disease Severity (Low-Risk, Submassive, Massive); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pulmonary Embolism Therapeutics Market is projected to grow at a CAGR of 6.3% , valued at USD 2.7 billion in 2024 and anticipated to reach approximately USD 4.1 bi... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Dimpleplasty Market By Procedure Type (Suturing Technique, Excisional Technique); By Gender (Male, Female); By Age Group (18–25, 26–35, 36–50, 50+); By End User (Cosmetic Surgery Clinics, Aesthetic Dermatology Practices, Hospital-Based Cosmetic Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dimpleplasty Market growing at 9.6% CAGR, expanding from USD 74.6 million in 2024 to USD 128.4 million by 2030, driven by cosmetic surgeryRead More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

Brachioplasty Market By Technique (Traditional Brachioplasty, Mini Brachioplasty, Extended Brachioplasty, Non-Invasive Techniques); By Gender (Male, Female); By End User (Hospitals, Ambulatory Surgical Centers, Aesthetic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Brachioplasty Market growing at 8.2%, CAGR, advancing from USD 1.3 billion in 2024 to USD 2.1 billion by 2030, with rising cosmetic surgery trends... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Neoantigen Targeted Therapy Market By Therapy Type (Personalized Neoantigen Vaccines, T-cell Based Therapies); By Cancer Indication (Melanoma, NSCLC, Glioblastoma, Bladder Cancer, Colorectal Cancer, Others); By Delivery Platform (mRNA, Peptide, Dendritic Cell, DNA-based); By End User (Academic Medical Centers, Specialty Cancer Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Neoantigen Targeted Therapy Market: Personalized Cancer Immunotherapy Moves From Concept to Recurrence-Risk Treatment (Last Updated on: June-2026)

The Global Neoantigen Targeted Therapy Market expanding at 28.4% CAGR, growing to USD 8.5 billion b... Read More

Published Date: DEC-2025 | No Of Pages:184 | $ 4485

Theranostics Market By Therapeutic Area (Oncology, Neurology, Cardiology, Others); By Technology Platform (Radiopharmaceuticals, Nanoparticle Systems, Antibody-Drug Conjugates, RNA-Based Platforms); By End User (Academic & Research Institutions, Specialty Clinics, Tertiary Hospitals, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Theranostics Market growing at 10.4% CAGR, expanding from USD 13.6 billion in 2024 to USD 24.8 billion by 2030, led by precision medicine... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Non-Muscle Invasive Bladder Cancer (NMIBC) Market By Therapy Type (Intravesical Therapy, Immuno-Oncology Agents, Surgery & Resection [TURBT], Emerging Therapies); By Route of Administration (Intravesical, Intravenous/Oral); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Muscle Invasive Bladder Cancer (NMIBC) Market is expected to grow steadily at a CAGR of 6.8%, expanding from USD 2.9 billion in 2024 to around USD 4.3 billion ... Read More

Published Date: DEC-2025 | No Of Pages:159 | $ 4485

Cancer Metabolism Based Therapeutics Market By Therapeutic Class (Enzyme Inhibitors, Immunometabolism Modulators, Multi-Pathway Inhibitors); By Cancer Type (Glioblastoma, Pancreatic Cancer, Acute Myeloid Leukemia, Renal Cell Carcinoma, Non-Small Cell Lung Cancer); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Metabolism Based Therapeutics Market is expected to grow at a CAGR of 10.8% , reaching a projected value of $6.7 billion by 2030 , up from $3.5 billion in 2... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Functional Endoscopic Sinus Surgery (FESS) Market By Product Type (Endoscopes, Powered Surgical Instruments, Balloon Dilation Systems, Navigation Systems); By Indication (Chronic Rhinosinusitis, Nasal Polyposis, Fungal Sinusitis & Tumors); By End User (Hospitals, ENT Clinics & Specialty Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Functional Endoscopic Sinus Surgery (FESS) Market projected to reach USD 5.2 billion by 2030 from USD 3.5 billion in 2024 at 6.8% CAGR, with key s... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Allogeneic Cell Therapy Market By Cell Type (Hematopoietic Stem Cells, Mesenchymal Stem Cells, NK Cells, T Cells, Others); By Therapeutic Application (Oncology, Neurology, Autoimmune Disorders, Cardiovascular, Orthopedics, Others); By Source (Bone Marrow, Peripheral Blood, Umbilical Cord Blood, iPSCs); By End User (Hospitals & Specialty Clinics, Academic & Research Institutes, Biopharma & CMOs, Regenerative Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Allogeneic Cell Therapy Market is projected to accelerate at a healthy CAGR of around 18.5%, growing from USD 4.7 billion in 2024 to USD 13.2 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Novel T-Cell Immunotherapy Market By Therapy Type (CAR-T Cell Therapy, TCR-T Cell Therapy, Tumor-Infiltrating Lymphocytes, Allogeneic T-Cell Therapy); By Indication (Hematologic Malignancies, Solid Tumors, Autoimmune Disorders); By Cell Source (Autologous, Allogeneic); By End User (Academic & Research Institutes, Specialty Cancer Centers, CDMOs, Community Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Novel T-Cell Immunotherapy Market: Approved CAR-T Base Moves Toward TILs, TCR-T, Allogeneic Platforms, and Solid Tumor Expansion (Last Updated on: June-2026)

The Global Novel T-Cell Immunotherapy Market was valued at USD 6.8 billion in 2024 and is projected to re... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Vascular Disrupting Agents (VDA) Market By Type of Agent (Tubulin-Binding Agents, Non-Tubulin-Binding Agents); By Cancer Indication (Non-Small Cell Lung Cancer, Ovarian Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Sarcomas); By Route of Administration (Intravenous, Intratumoral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vascular Disrupting Agents (VDA) Market is anticipated to expand at a CAGR of 8.5%, moving from USD 1.9 billion in 2024 to nearly USD 3.3 billion by 2030,... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

DNA Damage Response (DDR) Market By Therapeutic Class (PARP Inhibitors, ATM/ATR Inhibitors, WEE1 Inhibitors, CHK1/CHK2 Inhibitors, POLQ and Others); By Indication (Ovarian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Others); By End User (Academic & Research Institutes, Cancer Hospitals, Private Oncology Clinics, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DNA Damage Response (DDR) Market is projected to grow steadily, with an estimated value of USD 5.8 billion in 2024 and forecasted to reach USD 11.2 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

Peripheral Neuropathy Treatment Market By Treatment Type (Anticonvulsants, Antidepressants, Topical Analgesics, Non-Opioid Sodium-Channel Inhibitors, Opioid Analgesics, Spinal Cord Stimulation Devices, Peripheral Nerve Stimulation Devices, Physical Therapy and Rehabilitation, Nerve-Regeneration Therapies); By Application (Diabetic Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, Entrapment and Compression Neuropathy, Drug-Induced Peripheral Neuropathy, Autoimmune and Inflammatory Neuropathy, Nutritional Deficiency-Associated Neuropathy, Hereditary Peripheral Neuropathy); By End User (Hospitals, Neurology Clinics, Pain Management Clinics, Oncology Centers, Diabetes Care Centers, Ambulatory Surgical Centers, Physiotherapy and Rehabilitation Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Peripheral Neuropathy Treatment Market: Refractory Pain and Nerve-Repair Programs Challenge Generic Drug Cycling

The Global Peripheral Neuropathy Treatment Market was valued at USD 2.64 billion in 2025 and is projected to reach USD 4.18 billion by 2032, growing at a C... Read More

Published Date: JUL-2026 | No Of Pages:178 | $ 4485

Joint Pain Injections Market By Product Type (Corticosteroid Injections, Hyaluronic Acid Injections, PRP Injections, Stem Cell-Based Injections, Combination & Other Biologics); By Joint/Application (Knee, Hip, Shoulder, Ankle, Elbow, Others); By End User (Hospitals, Orthopedic Clinics, ASCs, Sports Medicine & Rehab Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Joint Pain Injections Market is projected to grow at a CAGR of 6.8% , reaching approximately USD 8.1 billion in 2030 , up from an estimated USD 5.... Read More

Published Date: DEC-2025 | No Of Pages:190 | $ 4485

Non-Hormonal Contraceptives Market By Product Type (Barrier Methods, Copper IUDs, Spermicides & Vaginal Gels, Fertility Awareness & Digital Tools); By Distribution Channel (Hospitals & Clinics, Retail Pharmacies & Drugstores, Online Platforms); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Hormonal Contraceptives Market is projected to expand steadily between 2024 and 2030, with an estimated valuation of USD 8.7 billion in 2024 and expected to reach arou... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

TCR Therapy Market By Target Antigen Type (Cancer-Testis Antigens, Neoantigens, Viral Antigens); By Indication (Synovial Sarcoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Colorectal Cancer, Others); By Technology Platform (Naturally Derived TCRs, Affinity-Enhanced TCRs, Gene-Edited TCRs, Allogeneic TCR T cells); By End User (Academic Cancer Centers, Specialized Immunotherapy Clinics, Tertiary Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TCR Therapy Market will surge at a remarkable CAGR of 38.4%, reaching USD 8.9 billion by 2030 from USD 0.9 billion in 2024, driven by cancer immun... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Sciatica Treatment Market By Treatment Type (Drug Therapy, Physical Therapy & Rehabilitation, Interventional Procedures, Surgical Interventions, Alternative Therapies); By Route of Administration (Oral, Injectable, Topical, Transdermal); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Pain Clinics, Rehabilitation Centers, Homecare & Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sciatica Treatment Market is forecast to grow at a steady CAGR of 5.4%, valued at USD 7.8 billion in 2024 and projected to reach nearly USD 10.7 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Short Bowel Syndrome Market By Drug Class (GLP-2 Analogues, Growth Hormones, Antidiarrheals, Proton Pump Inhibitors, Others); By Route of Administration (Parenteral, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Short Bowel Syndrome Market is anticipated to grow at a CAGR of 8.7 %, valued at USD 1.62 billion in 2024 and projected to reach USD 2.71 billion by 2030,... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Neovaginal Surgery Market By Surgical Technique (Penile Inversion, Sigmoid Colon, Peritoneal, Skin/Buccal Graft); By Indication (Gender-Affirming Surgery, Congenital Anomalies, Reconstructive Oncology/Trauma); By End User (Academic Medical Centers, Specialty Clinics, Public Hospitals, Congenital Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neovaginal Surgery Market Is projected to grow at a robust CAGR of 9.8% , reaching a total market value of approximately USD 3.2 billion in 2030 , up from... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Appendicitis Treatment Market By Treatment Type (Open Appendectomy, Laparoscopic Appendectomy, Robotic-Assisted Appendectomy, Non-Surgical Antibiotic Therapy); By Route of Administration (Intravenous, Oral, Parenteral); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Appendicitis Treatment Market: Antibiotics-First Care Expands Patient Choice While Laparoscopic Surgery Retains the Core Revenue Pool

The Global Appendicitis Treatment Market was estimated to reach USD 4.52 billion in 2025 and is projected to grow to USD 7.55 billion ... Read More

Published Date: JUL-2026 | No Of Pages:153 | $ 4485

Biofilms Treatment Market By Product Type (Topical Agents, Enzymatic Disruptors, Systemic Antibiotics, Surface Coatings, Novel Therapeutics); By Application (Chronic Wounds, Orthopedic Implant Infections, Cardiovascular Devices, Dental & Oral Health, Urology); By End User (Hospitals & Surgical Centers, Wound Care Clinics, Dental Clinics, Veterinary & Military Care); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Biofilms Treatment Market: Procedure Avoidance and Biofilm-Disrupting Combinations Define Commercial Value

The Global Biofilms Treatment Market was valued at USD 3.37 billion in 2025 and is projected to reach USD 6.00 billion by 2032, expanding at an 8.6% CAGR, accord... Read More

Published Date: JUL-2026 | No Of Pages:189 | $ 4485

Leptospirosis Market By Treatment Type (Antibiotics, Supportive Care); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

How Large Is the Leptospirosis Market and What Is Shaping Its Clinical Landscape?  – (Updated On: 27-Aug-2026)

The Global Leptospirosis Market was valued at USD 600 million in 2025 and is projected to reach USD 950 million by 2032, expanding at a CAGR ... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Cartilage Degeneration Market By Treatment Type (Non-Surgical [Pharmacological, Biologics, Injections], Surgical [Implants, Grafts, Regenerative Therapies]); By Application (Knee, Hip, Ankle, Shoulder, Others); By End User (Hospitals, Specialty Orthopedic & Sports Medicine Clinics, Ambulatory Surgical Centers, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cartilage Degeneration Market valued at USD 9.7 billion in 2024 and projected to reach USD 15.3 billion by 2030 at 6.8% CAGR, fueled by cartilage ... Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Gerontology Market By Product & Service Type (Assistive Technologies, Geriatric Pharmaceuticals, Long-Term Care Services, Digital Health & Monitoring Tools, Wellness & Preventive Services); By Application (Chronic Disease Management, Cognitive Health and Dementia Care, Mobility and Fall Prevention, Mental Health Support, End-of-Life and Palliative Care, Preventive and Lifestyle Medicine); By End User (Hospitals and Geriatric Clinics, Long-Term Care Facilities, Home-Based Care Settings, Community Health Centers, Individual Consumers and Families); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gerontology Market is expected to grow at a robust CAGR of 6.3%, valued at USD 298.7 billion in 2024 and projected to hit USD 455.1 billion by 2030, fuele... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Lumpectomy Market By Surgery Type (Standard Lumpectomy, Oncoplastic Lumpectomy, Image-Guided Lumpectomy); By Technology Used (Wire Localization, Radiofrequency & Magnetic Seed Localization, Vacuum-Assisted Excision Devices); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Cancer Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lumpectomy Market is expected to grow at a robust CAGR of 6.1%, with a valuation of USD 2.3 billion in 2024, projected to reach USD 3.3 billionRead More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Dupixent Market By Indication (Atopic Dermatitis, Asthma, Chronic Rhinosinusitis with Nasal Polyps, Eosinophilic Esophagitis, Prurigo Nodularis); By Age Group (Adults, Adolescents, Pediatrics); By Route of Administration (Prefilled Syringes, Auto-injectors); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dupixent Market is forecasted to expand with a CAGR of 13.8%, valued at USD 9.8 billion in 2024, and expected to achieve USD 21.3 billion by 2030<... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Lysosomal Storage Disease Treatment Market By Disease Type (Pompe Disease, Gaucher Disease, Fabry Disease, Mucopolysaccharidoses, Niemann-Pick Disease, Metachromatic Leukodystrophy, Acid Sphingomyelinase Deficiency, Krabbe Disease, Batten Disease, Others); By Treatment Type (Enzyme Replacement Therapy, Substrate Reduction Therapy, Pharmacological Chaperones, CNS-Targeted Biologics, Gene Therapy, Hematopoietic Stem Cell Transplantation, Supportive & Disease-Specific Therapies); By Route/Delivery Mode (Intravenous, Oral, Intracerebroventricular/Intrathecal, Ex Vivo Cell-Based Infusion); By Care Setting/Distribution Channel (Hospital & Outpatient Infusion Centers, Specialty Pharmacies, Home Infusion Services, Gene Therapy & Transplant Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Lysosomal Storage Disease Treatment Market: Newborn Screening, CNS Delivery, and Gene Therapy Reshape Rare-Disease Treatment

The Global Lysosomal Storage Disease Treatment Market was valued at USD 4.83 billion in 2025 and is projected to reach USD 6.94 billion by 2032... Read More

Published Date: JUL-2026 | No Of Pages:155 | $ 4485

Diabetic Ketoacidosis Treatment Market By Treatment Type (Insulin Therapy, Intravenous Fluids, Electrolyte Replacement, Dextrose Therapy, Subcutaneous Insulin Protocols, Supportive and Complication Management); By Fluid Type (Normal Saline, Balanced Crystalloids, Dextrose-Containing Fluids); By Monitoring Method (Blood Glucose Monitoring, Blood Ketone Monitoring, Electrolyte Testing, Blood Gas Analysis, Continuous Glucose-Ketone Monitoring); By Care Setting (Emergency Department Care, Intensive Care Unit Care, General Ward/Inpatient Care, Ambulatory and Follow-Up Care); By End User (Hospitals, Emergency Care Centers, Specialty Diabetes Clinics, Ambulatory Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Diabetic Ketoacidosis Treatment Market Expands Through Hospital Utilization, Intensive Monitoring, and Continuous Ketone Detection

The Global Diabetic Ketoacidosis Treatment Market was valued at USD 912 million in 2025 and is projected to reach USD 1.26 billion by 203... Read More

Published Date: JUL-2026 | No Of Pages:187 | $ 4485

Binge-Eating Disorder Treatment Market By Treatment Type (Psychological & Behavioral Therapy, Pharmacotherapy, Guided Self-Help & Group Therapy, Multidisciplinary Supportive Care); By Care Delivery Model (In-Person Outpatient Care, Telehealth & Virtual Therapy, Hybrid Care Programs, Digital Therapeutic Platforms); By End User (Specialty Eating-Disorder Clinics, Outpatient Therapy Centers, Hospitals & Health Systems, Digital Mental Health Platforms); By Patient Group (Adults With Moderate-to-Severe BED, Patients With Psychiatric Comorbidities, Patients With Obesity & Metabolic Comorbidities, Adolescents); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Binge Eating Disorder Treatment Market: Therapy Access, Generic Competition, and Integrated Care Reshape Treatment Economics

The Global Binge Eating Disorder Treatment Market was valued at USD 716.8 million in 2025 and is projected to reach USD 1.23 billion by 2032, g... Read More

Published Date: JUL-2026 | No Of Pages:157 | $ 4485

Tremfya (Guselkumab) Market By Product Type (Injectable Biologic); By Application (Plaque Psoriasis, Psoriatic Arthritis, Pipeline Indications – Crohn’s Disease, Ulcerative Colitis); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tremfya (Guselkumab) Market is forecast to expand at a CAGR of 9.1%, valued at USD 3.1 billion in 2024 and reaching nearly USD 5.8 billion by 2030, driven... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Cyclosporine Market By Therapeutic Application (Transplantation, Autoimmune Disorders, Ophthalmology); By Formulation Type (Oral Capsules, Injectables, Topical Formulations); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cyclosporine Market will see consistent expansion at a CAGR of 6.1%, rising from USD 1.53 billion in 2024 to USD 2.19 billion by 2030, supported by strong... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Thoracic Aortic Aneurysm Market By Product Type (Stent Grafts, Synthetic Grafts, Surgical Instruments, Imaging Systems); By Approach (Endovascular Repair [TEVAR], Open Surgical Repair); By Indication (Ascending Aortic Aneurysms, Descending Thoracic Aneurysms, Thoracoabdominal Aneurysms); By End User (Hospitals, Specialty Cardiac Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Thoracic Aortic Aneurysm Market is set to witness stable expansion at a CAGR of 8.4%, increasing from USD 2.5 billion in 2024 to USD 4.1 billion by 2030, ... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Anti-Biofilm Wound Dressing Market By Product Type (Foam Dressings, Hydrofiber Dressings, Alginate Dressings, Combination Dressings); By Wound Type (Chronic Wounds, Acute Wounds); By End User (Hospitals, Specialty Wound Care Clinics, Ambulatory Surgical Centers, Home Healthcare, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anti-Biofilm Wound Dressing Market is set to grow at a sustained CAGR of 6%, climbing from USD 790 million in 2024 to more than USD 1.1 billion by 2030, p... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Male Urinary Incontinence Market By Product Type (Catheters, Artificial Urinary Sphincters, Male Slings, Absorbent Products, External Clamps); By Application (Stress Incontinence, Urge Incontinence, Overflow Incontinence, Mixed Incontinence); By End User (Hospitals, Specialty Urology Clinics, Ambulatory Surgical Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Male Urinary Incontinence Market will witness a CAGR of 6.8%, valued at USD 3.4 billion in 2024, expected to reach nearly USD 5.1 billion by 2030, driven ... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Recombinant Human Endostatin Market By Product Type (Therapeutic-Grade Recombinant Human Endostatin Injection, Research-Grade Recombinant Human Endostatin Protein); By Application (Advanced and Metastatic Non-Small Cell Lung Cancer, Malignant Pleural and Thoracoabdominal Effusion, Other Solid Tumors, Angiogenesis and Endothelial-Cell Research); By End User (Hospitals and Oncology Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Preclinical and Laboratory Research Facilities); By Distribution Channel (Hospital Procurement and Reimbursement Channels, Direct Research Supply, Laboratory Product Distributors); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Recombinant Human Endostatin Market - China-Centered Therapeutic Demand Defines the Market

The Global Recombinant Human Endostatin Market was valued at USD 0.158 billion in 2025 and is projected to reach USD 0.278 billion by 2032, exp... Read More

Published Date: Aug-2026 | No Of Pages:199 | $ 4485

Hemangioma Treatment Market By Treatment Type (Propranolol, Corticosteroids, Laser Therapy, Surgical Excision, Other Treatments); By Disease Type (Infantile Hemangioma, Congenital Hemangioma, Acquired Hemangioma); By End User (Hospitals, Specialty Clinics, Ambulatory Care Centers, Others); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Hemangioma Treatment Market Outlook: How Large Is the Market and What Is Driving Therapeutic Innovation? – (Updated On: 07-Sep-2026)

The Global Hemangioma Treatment Market was valued at USD 420 million in 2025 and is projected to reach USD 600 m... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Drug Repurposing Market By Therapeutic Area (Oncology, Neurology, Infectious Diseases, Cardiovascular Disorders, Autoimmune and Inflammatory Conditions, Others); By Drug Type (Small Molecules, Biologics); By Technology Platform (Computational Modeling and AI-Based Screening, High-Throughput Screening, Genomics-Driven Repurposing, Others); By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

What Is the Drug Repurposing Market Size and Why Are Existing Medicines Becoming Strategic Development Assets?  – (Updated On: 01-Sep-2026)

The Global Drug Repurposing Market was valued at USD 4.85 billion in 2025 and is projected to reach USD 8.72 billion ... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Peripheral Artery Disease (PAD) Market By Treatment Type (Pharmacological, Surgical, Endovascular); By Diagnostic Modality (ABI Testing, Ultrasound, CTA, MRA); By End User (Hospitals, Diagnostic Imaging Centers, ASCs, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peripheral Artery Disease (PAD) Market will witness steady expansion at a CAGR of 6.3% from 2024 to 2030, rising from USD 6.5 billion in 2024 to USD 10.2 billion b... Read More

Published Date: NOV-2025 | No Of Pages:191 | $ 4485

Light Therapy Market By Device Type (Full-body Light Boxes, Portable Devices, Wearable Units); By Application (Dermatology, Seasonal Affective Disorder, Neurological Rehabilitation, Sleep Disorders, Wound Healing); By End User (Hospitals & Clinics, Dermatology & Aesthetic Centers, Wellness Centers & Spas, Home Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Light Therapy Market, valued at USD 1.2 billion in 2024, is expected to grow at a steady CAGR of 5.8%, reaching USD 1.68 billion by 2030, driven by i... Read More

Published Date: NOV-2025 | No Of Pages:178 | $ 4485

Breast Conserving Surgery Market By Surgical Technique (Traditional, Robotic-Assisted, IORT, Partial Breast Radiation); By End-User (Hospitals, Oncology Clinics, ASCs, Diagnostic Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Breast Conserving Surgery Market is valued at USD 4.7 billion in 2024 and projected to grow at a 5.1% CAGR, reaching USD 7.7 billion by 2030, driven by ri... Read More

Published Date: NOV-2025 | No Of Pages:177 | $ 4485

Dermal Regeneration Market By Product Type (Stem Cell Therapies, Growth Factor Therapies, Skin Substitutes, Wound Dressings); By Application (Burns, Chronic Wounds, Cosmetic Dermatology); By End User (Hospitals, Specialty Clinics, Home Healthcare, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dermal Regeneration Market is projected at USD 9.7 billion in 2024 and growing at a robust 8.5% CAGR to USD 16.4 billion by 2030, offering deep ma... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Circadian Rhythm Sleep Disorder Market By Disorder Type (Delayed Sleep Phase Disorder, Shift Work Sleep Disorder, Non-24-Hour Sleep-Wake Disorder, Advanced Sleep Phase Disorder, Jet Lag Disorder); By Treatment Type (Pharmacological, Light Therapy, Digital Therapeutics, Wearables); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By End User (Sleep Clinics, General Hospitals, Employers, Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Circadian Rhythm Sleep Disorder Market is projected to reach USD 3.9 billion by 2030 from USD 2.2 billion in 2024, expanding at a CAGR of 9.5%, drive... Read More

Published Date: NOV-2025 | No Of Pages:183 | $ 4485

Immuno-Oncology Antibodies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, IO-Active ADCs, CAR-T, TCR-T, NK & γδ-T Cell Therapies); By Cancer Type (Solid Tumors, Hematologic Malignancies); By Line of Therapy (First-Line, Second-Line, Later-Line); By Biomarker Class (PD-L1, MSI-H/dMMR, HER2, BCMA, GPRC5D, CLDN18.2 and Others); By Geography (United States, Europe, Asia-Pacific, Latin America), Segment Revenue Estimation & Forecast, 2025–2035

1. Introduction & Strategic Context

The Global Immuno-Oncology market for monoclonal antibodies & cell therapies expands from USD 55–60B in 2025 to ~USD 140B by 2035, propelled by deeper first-line penetration of PD-1/PD... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

Endometriosis and Uterine Fibroid Therapeutics Market By Therapy Type (Combined Oral Contraceptives, Progestogens & LNG-IUS, GnRH Agonists, Oral GnRH Antagonists, Emerging Non-Hormonal Therapies); By Disease Type (Endometriosis, Uterine Fibroids); By Distribution Channel (Hospitals & Surgical Centers, Specialty Gynecology Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2025–2035.

1. Introduction and Strategic Context

The Global Endometriosis & Uterine Fibroid Therapeutics Market is entering a decade of accelerated growth, expanding from USD 1.60 billion in 2025 to USD 5.50 billion by 2035,... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 5485

Hadron Therapy Market By Treatment Type (Proton Therapy, Heavy Ion Therapy, Other Emerging Therapies); By Technology (Particle Accelerators, Treatment Planning Systems); By End User (Hospitals & Cancer Treatment Centers, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Hadron Therapy Market: Proton Therapy Adoption and Carbon Ion Pipeline Redefine Particle-Based Cancer Treatment (Last Updated on: June-2026)

The Global Hadron Therapy Market is poised for steady growth, expanding at a 7.3% CAGR from 2024 to 2030, growing from USD... Read More

Published Date: NOV-2025 | No Of Pages:182 | $ 4485

Long-Acting Injectables (LAIS) Market By Product Type (Injectable Depot Formulations, Implantable LAIs); By Therapeutic Application (Psychiatric Disorders, HIV Treatment, Chronic Pain Management, Endocrine Disorders, Others); By End-User (Hospitals, Clinics, Specialty Pharmacies, Contract Research Organizations, Primary Care Physicians); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Long-Acting Injectables (LAIS) Market is set to witness a significant rise, driven by increasing demand for advanced therapies with better patient compliance and reduced frequency of administration. Valued at Read More

Published Date: NOV-2025 | No Of Pages:181 | $ 4485

Spinal Cord Injury (SCI) Treatment Market By Treatment Type (Pharmaceuticals, Medical Devices, Stem Cell Therapies, Rehabilitation Technologies); By End User (Hospitals, Rehabilitation Centers, Home Care, CROs); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spinal Cord Injury (SCI) Treatment Market is projected to grow at a 7.4% CAGR, rising from USD 7.5 billion in 2024 to USD 12.1 billion by 2030, driven by advancements in n... Read More

Published Date: NOV-2025 | No Of Pages:176 | $ 4485

Cutaneous T-cell Lymphoma (CTCL) Market By Treatment Modality (Immunotherapy, Chemotherapy, Phototherapy, Topical Therapies); By Distribution Channel (Hospitals, Clinics, Pharmacies & Online); By End User (Oncology Hospitals, Private Clinics, Research Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cutaneous T-Cell Lymphoma (CTCL) Market is projected to grow from USD 1.3 billion in 2024 to USD 2.5 billion by 2030, at a CAGR of 8.5%, driven by advance... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

Movement Disorder Market By Disease Type (Parkinsons Disease, Essential Tremor, Dystonia, Huntingtons Disease); By Treatment Modality (Pharmacological, Surgical, Gene Therapy, Physical Therapy); By End-User (Hospitals & Clinics, Home Care Settings, Research Institutes, CROs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Movement Disorder Market is valued at USD 7.5 billion in 2024 and is projected to grow at a CAGR of 8.5%, reaching USD 13.5 billion by 2030, driven by ris... Read More

Published Date: NOV-2025 | No Of Pages:183 | $ 4485

Bone Marrow Aspirate Concentrates (BMAC) Market By Product Type (Aspiration Kits, Concentrators & Processing Equipment); By Application (Orthopedics & Musculoskeletal Disorders, Cardiovascular Diseases, Neurological Disorders, Others); By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Research & Academic Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bone Marrow Aspirate Concentrates (BMAC) Market is valued at USD 2.4 billion in 2024, and is projected to reach USD 5.13 billion by 2030,... Read More

Published Date: NOV-2025 | No Of Pages:161 | $ 4485

Vaginal Rejuvenation Market By Treatment Type (Laser-Based Treatments, Radiofrequency Energy, Surgical Procedures); By Procedure Type (Non-Invasive, Minimally Invasive); By End-User (Cosmetic Clinics, Gynecology Clinics, Hospitals, Medical Spas); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vaginal Rejuvenation Market is projected to grow at a CAGR of 8.5%, rising from $1.2 billion in 2024 to $2.1 billion by 2030, driven by increasing demand ... Read More

Published Date: NOV-2025 | No Of Pages:179 | $ 4485

Oncology Nutrition Market By Product (Oral Nutritional Supplements [Ready-to-Drink Supplements, Powdered Supplements, Puddings and Semi-Solid Supplements, High-Protein Supplements, Energy-Dense Supplements, Cancer-Specific and Immunonutrition Formulas], Enteral Nutrition [Standard Polymeric Formulas, High-Protein Formulas, Peptide-Based Formulas, Fibre-Enriched Formulas, Disease-Specific Formulas, Feeding Pumps and Administration Supplies], Parenteral Nutrition [Amino Acid Solutions, Lipid Emulsions, Glucose Solutions, Trace Elements and Micronutrient Additives, Multi-Chamber Parenteral Nutrition Bags, Infusion Pumps and Administration Supplies]); By Application (Cancer-Related Malnutrition, Cancer Cachexia and Muscle Wasting, Treatment-Related Appetite Loss, Dysphagia and Swallowing Impairment, Chemotherapy-Related Nutritional Support, Radiotherapy-Related Nutritional Support, Perioperative Oncology Nutrition, Gastrointestinal Malabsorption, Intestinal Failure and Bowel Obstruction, Post-Treatment Recovery and Rehabilitation); By Cancer Type (Head and Neck Cancer, Gastrointestinal Cancer [Oesophageal Cancer, Gastric Cancer, Colorectal Cancer, Pancreatic Cancer], Lung Cancer, Breast Cancer, Gynaecological Cancer, Urological Cancer, Haematological Malignancies, Other Solid Tumours); By End User (Hospitals and Cancer Centres, Outpatient Oncology Clinics, Specialist Nutrition Clinics, Home-Care and Home-Infusion Providers, Ambulatory Surgical Centres, Long-Term Care and Rehabilitation Facilities, Pharmacies and Medical-Nutrition Distributors); By Distribution Channel (Hospital Pharmacies and Formularies, Retail Pharmacies, Medical-Nutrition Distributors, Home-Care and DME Suppliers, Online and Direct-to-Consumer Channels); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Oncology Nutrition Market: Screening Gaps, Treatment Toxicity, and Home-Care Refills Shape Commercial Demand

The Global Oncology Nutrition Market is projected to grow from USD 6.02 billion in 2025 to USD 10.00... Read More

Published Date: JUL-2026 | No Of Pages:174 | $ 4485

Renal Anemia Treatment Market By Treatment Type (Erythropoiesis-Stimulating Agents, Iron Supplements [Oral Iron, Intravenous Iron], HIF-Prolyl Hydroxylase Inhibitors, Red Blood Cell Transfusions, Hepcidin-Targeted and Anti-Inflammatory Therapies, Other Supportive Treatments); By Application (Non-Dialysis-Dependent Chronic Kidney Disease, Hemodialysis-Dependent Chronic Kidney Disease, Peritoneal Dialysis-Dependent Chronic Kidney Disease, ESA-Hyporesponsive Renal Anemia, Iron-Deficiency and Iron-Restricted Renal Anemia); By End User (Hospitals, Dialysis Centers, Nephrology Clinics, Ambulatory Infusion Centers, Homecare Settings, Retail and Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Renal Anemia Treatment Market: Pre-Dialysis Treatment Gaps and Oral HIF-PHI Access Shift Value Beyond Injectable ESAs

The Global Renal Anemia Treatment Market was valued at USD 6.29 billion in 2025 and is projected to reach USD 9.84 billion by... Read More

Published Date: JUL-2026 | No Of Pages:192 | $ 4485

Small Molecule Targeted Cancer Therapy Market By Therapy Type (Kinase Inhibitors, PARP Inhibitors, Apoptosis Inducers); By Cancer Type (Lung Cancer, Breast Cancer, Melanoma, Colorectal Cancer, Hematologic Cancers, Others); By Route of Administration (Oral, Injectable); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Molecule Targeted Cancer Therapy Market will grow at a promising CAGR of 7.3%, valued at $64.5 billion in 2024 and projected to reach $99.6 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:177 | $ 4485

Neuroprotection Market By Product Type (Drugs, Devices); By Therapeutic Application (Neurodegenerative Diseases, Traumatic Brain Injury, Stroke and Ischemic Disorders); By End User (Hospitals & Clinics, Research Institutions, Contract Research Organizations, Home Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neuroprotection Market is expected to witness significant expansion at a CAGR of 10.4%, rising from USD 5.6 billion in 2024 to USD 10.2 billion by 2030, s... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Circadian Rhythm Sleep Treatment Market By Treatment Type (Pharmacological Therapies, Non-Pharmacological Therapies); By Disorder Type (Delayed Sleep Phase Disorder, Advanced Sleep Phase Disorder, Non-24-Hour Sleep-Wake Disorder, Shift Work Sleep Disorder, Jet Lag Disorder); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Circadian Rhythm Sleep Treatment Market will witness a steady CAGR of 6.2%, valued at $1.72 billion in 2024, expected to grow and reach $2.61 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:187 | $ 4485

Aortic Stenosis Treatment Market By Treatment Type (Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty, Medications); By End-User (Hospitals, Specialized Cardiac Clinics, Ambulatory Surgical Centers, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aortic Stenosis Treatment Market is expected to grow significantly, driven by increasing global awareness of cardiovascular diseases and the growing aging population. In 2024, the market i... Read More

Published Date: NOV-2025 | No Of Pages:162 | $ 4485

Postherpetic Neuralgia (PHN) Treatment Market By Treatment Type (Oral Medications, Topical Treatments, Injectables); By Drug Class (Anticonvulsants, Tricyclic Antidepressants, Opioids, Others); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Postherpetic Neuralgia (PHN) Treatment Market will witness a robust growth with an estimated CAGR of 5.1%Read More

Published Date: NOV-2025 | No Of Pages:166 | $ 4485

Compartment Syndrome Monitoring Market By Product Type (Pressure Monitoring Systems, Wearable Sensors, Diagnostic Kits); By Application (Trauma & Emergency Care, Post-Surgical Monitoring, Military & Field Applications); By End User (Hospitals & Trauma Centers, Ambulatory Surgical Centers, Emergency Medical Services, Military); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Compartment Syndrome Monitoring Market is anticipated to experience a significant growth trajectory, with an expected CAGR of 7.2% , projected to reach Read More

Published Date: NOV-2025 | No Of Pages:150 | $ 4485

Trauma Care Centers Market By Facility Type (Level I, Level II & III, Mobile & Rural Units); By Injury Type (Road Traffic, Falls, Penetrating/Blunt, Burn & Chemical); By End User (Public Hospitals, Private Trauma Facilities, Military & Defense, Academic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trauma Care Centers Market will witness a steady CAGR of 6.3% , valued at $24.5 billion in 2024 , expected to appreciate and reach appro... Read More

Published Date: NOV-2025 | No Of Pages:188 | $ 4485

Progressive Multifocal Leukoencephalopathy (PML) Treatment Market By Treatment Approach (Immune Restoration, Antiviral Therapies, Checkpoint Inhibitors, Virus-Specific T-Cell Therapies, Supportive Care); By Underlying Condition (HIV/AIDS, Multiple Sclerosis and Drug-Associated PML, Hematological Malignancies, Transplantation, Immune Disorders); By Care Setting (Academic Medical Centers, Specialty Hospitals, Cancer and Transplant Centers, Neurology Clinics, Rehabilitation Facilities); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2026–2032

Progressive Multifocal Leukoencephalopathy Treatment Market: Brincidofovir, T-Cell Therapy, and Biomarker-Guided Immunotherapy Reshape an Untreated Rare Disease

The Global Progressive Multifocal Leukoencephalopathy (PML) Treatment Market is projected to grow from USD ... Read More

Published Date: JUL-2026 | No Of Pages:184 | $ 4485

Bioidentical Hormones Market By Product Type (Hormone Replacement Therapies, Compounded Hormones); By Application (Menopause Treatment, Andropause Treatment, Thyroid Disorders, Other Applications); By End User (Pharmaceutical Companies, Compounding Pharmacies, Wellness Centers, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bioidentical Hormones Market is poised for strong growth in the 2024-2030 period, driven by increasing demand for hormone replacement therapies (HRT) that use hormones structurally identical to those the b... Read More

Published Date: NOV-2025 | No Of Pages:165 | $ 4485

Clostridium Difficile Infection Treatment Market By Treatment Type (Antibiotics, Immunotherapies, Microbiota Restoration Therapies, Others); By Route of Administration (Oral, Intravenous, Rectal); By End User (Hospitals, Ambulatory Surgical Centers, Long-Term Care Facilities, Home Healthcare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Clostridium Difficile Infection (CDI) Treatment Market is projected to grow at a CAGR of 5.9%, reaching $2.87 billion by 2030, up from $1.91 billion in 2024Read More

Published Date: NOV-2025 | No Of Pages:155 | $ 4485

Peptide Receptor Radionuclide Therapy (PRRT) Market By Product Type (Radiopharmaceuticals, Peptides); By Application (Neuroendocrine Tumors, Other Cancers); By End-User (Hospitals and Cancer Centers, Research Institutes and Clinical Trials); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Peptide Receptor Radionuclide Therapy Market: Theranostic Radiopharmaceuticals Move from Advanced NET Control Toward Earlier-Line and Alpha-Emitter Innovation (Last Updated on: June-2026)

The Global Peptide Receptor Radionuclide Therapy Market was valued at USD 3... Read More

Published Date: NOV-2025 | No Of Pages:164 | $ 4485

Fibroblast Growth Factor Receptor (FGFR) Inhibitor Market By Drug Type (Selective Inhibitors, Pan-FGFR Inhibitors); By Application (Cancer Treatment, Other Therapies); By End User (Hospitals, Cancer Research Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

FGFR Inhibitors Market Outlook: Biomarker-Driven Precision Oncology Landscape (Last Updated on: June-2026)

The Global Fibroblast Growth Factor Receptor (FGFR) Inhibitor Market was valued at USD 1.8 billion in 2024 and is ex... Read More

Published Date: NOV-2025 | No Of Pages:163 | $ 4485

Autologous Conditioned Plasma Market By Product Type (Pure PRP Systems, Leukocyte-Rich PRP Systems); By Application (Orthopedic & Sports Injuries, Aesthetic Medicine, Wound Healing, Dental Surgery, Veterinary); By End User (Hospitals, Specialty Clinics, Research Institutes, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autologous Conditioned Plasma Market will witness a robust CAGR of 8.86 % , valued at $980 million in 2024 , and is expected to appreciate and reach near... Read More

Published Date: NOV-2025 | No Of Pages:151 | $ 4485

Psychotic Disorder Treatment Market By Drug Class (Atypical Antipsychotics, Typical Antipsychotics, Novel Mechanism Drugs); By Treatment Modality (Pharmacological, Psychotherapy, Digital Therapeutics, Community-Based Programs); By End User (Psychiatric Hospitals, Outpatient Clinics, Community Mental Health Centers, Digital Health Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Psychotic Disorder Treatment Market will witness a moderate but steady CAGR of 5.2%, valued at $13.2 billion in 2024 and expected to reach nearly $18.4 billion by ... Read More

Published Date: NOV-2025 | No Of Pages:169 | $ 4485

Radioimmunotherapy Market By Product Type (Monoclonal Antibodies, Radiopharmaceuticals); By Application (Cancer Treatment, Diagnostic Imaging); By End-User (Hospitals & Oncology Centers, Pharmaceutical & Biotech Companies, Research Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Radioimmunotherapy Market: Pretargeted Platforms Revive Antibody-Guided Radiation Beyond CD20 Lymphoma (Last Updated on: June-2026)

The Global Radioimmunotherapy Market is set to grow at a CAGR of 7.2%, valued at USD 1.6 billion in 2024 and projected to reach USD... Read More

Published Date: NOV-2025 | No Of Pages:187 | $ 4485

Triple-Negative Breast Cancer Treatment Market By Treatment Type (Chemotherapy, Immunotherapy, Antibody-Drug Conjugates, PARP Inhibitors, Surgery, Radiation Therapy, Other Supportive and Targeted Treatments); By Disease Stage (Early-Stage TNBC, Locally Advanced TNBC, Metastatic TNBC, Recurrent TNBC); By Biomarker Status (PD-L1-Positive TNBC, Germline BRCA1/2-Mutated TNBC, PD-L1-Negative or Checkpoint-Inhibitor-Ineligible TNBC, Biomarker-Unselected TNBC); By End User (Hospitals and Comprehensive Cancer Centers, Specialty Oncology Clinics, Ambulatory Infusion Centers, Academic and Research Institutes); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

Triple-Negative Breast Cancer Treatment Market Enters a First-Line ADC and Biomarker-Directed Growth Cycle


The Global Triple Negative Breast Cancer (TNBC) Treatment Market was valued at USD 4.68 billion in 2025 and is projected to reach USD 8.50 billion by 203... Read More

Published Date: Aug-2026 | No Of Pages:165 | $ 4485

Alcoholic Hepatitis Treatment Market By Treatment Type (Supportive Care & Nutritional Therapy, Corticosteroid Therapy, Adjunctive Pharmacological Therapy, Alcohol Use Disorder Treatment, Liver Transplantation, Emerging Therapies); By Drug Class (Corticosteroids, N-Acetylcysteine, Alcohol Use Disorder Drugs, Investigational Disease-Modifying Drugs, Other Supportive Medicines); By Disease Severity (Mild Alcoholic Hepatitis, Moderate Alcoholic Hepatitis, Severe Alcoholic Hepatitis); By Route of Administration (Oral, Intravenous/Parenteral); By End User (Hospitals, Transplant Centers, Hepatology Clinics, Outpatient Addiction Care Centers, Research Institutes & Clinical Trial Sponsors); By Region, Segment Revenue Estimation, Forecast, 2026–2032

Alcoholic Hepatitis Treatment Market: High Inpatient Costs, Steroid Nonresponse, and Phase 3 Drug Development Reshape Commercial Opportunity

The Global Alcoholic Hepatitis Treatment Market is projected to expand from USD 2.85 billion in 2025 to USD 4.07 billion by 203... Read More

Published Date: JUL-2026 | No Of Pages:182 | $ 4485

Urinary Tract Infection Treatment Market By Drug Class (Quinolones, Beta-Lactams & Cephalosporins, Sulfonamides, Tetracyclines, Aminoglycosides, Other Treatments); By Clinical Type (Uncomplicated UTI, Complicated UTI, Recurrent UTI, Catheter-Associated UTI); By Care Setting (Hospitals, Clinics, Specialty Care Centers, Community Healthcare Facilities); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Providers & Telemedicine Platforms); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

Urinary Tract Infection Treatment Market: Resistance, New Oral Antibiotics, and Pharmacy-Led Care Reshape Commercial Value

The Global Urinary Tract Infection Treatment Market was valued at USD 9.23 billion in 2025 and is projected to reach USD 10.98 billion by 2032, g... Read More

Published Date: JUL-2026 | No Of Pages:155 | $ 4485

Transplantation Market By Product Type (Solid Organ Transplants, Bone Marrow Transplants, Corneal Transplants); By Application (End-Stage Organ Failure, Cancer Treatment, Ophthalmic Treatments); By End User (Hospitals & Transplant Centers, Research Institutions, Pharmaceutical Companies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transplantation Market is forecast to achieve a CAGR of 4.5%, increasing from USD 22.3 billion in 2024 to USD 29.5 billion by 2030, propelled by innovatio... Read More

Published Date: NOV-2025 | No Of Pages:196 | $ 4485

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Treatment Market By Drug Type (Immunoglobulins [IVIg and SCIg], Biologics, Corticosteroids, Immunosuppressants, Other Therapies); By Treatment Approach (First-Line Therapies, Second-Line Therapies, Maintenance Therapies, Rescue Therapies, Advanced Targeted Therapies); By Route of Administration (Intravenous, Subcutaneous, Oral, Other Administration Routes); By End User (Hospitals, Neurology Clinics, Specialty Infusion Centers, Home Healthcare Providers, Research and Clinical Institutes); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Direct Procurement and Infusion Networks, Online and Mail-Order Specialty Channels); By Therapy Setting (Hospital-Based Treatment, Specialist Outpatient Care, Home-Based Immunoglobulin Administration, Plasma Exchange Centers, Long-Term Maintenance Care); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Chronic Inflammatory Demyelinating Polyneuropathy Treatment Market: FcRn Adoption Reshapes an Immunoglobulin-Dominated Category

The Global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Treatment Market was valued at USD 2.21 billion in 2025 and is projected... Read More

Published Date: JUL-2026 | No Of Pages:186 | $ 4485

Cardiac Arrest Treatment Market By Product Type (Automated & Professional Defibrillators, CPR & Mechanical Compression Devices, Emergency Drugs, Airway & Vascular Access Products, Patient Monitoring & Temperature Management Systems, Wearable Cardioverter-Defibrillators, Implantable Cardioverter-Defibrillators); By Care Pathway (Basic Life Support, Advanced Cardiovascular Life Support, Diagnostic Evaluation, Post-Cardiac Arrest Critical Care, Secondary Prevention); By Diagnostic Assessment (ECG & Rhythm Monitoring, Blood Testing, Echocardiography, X-Ray, CT & MRI, Nuclear Cardiac Imaging, Cardiac Catheterisation, Electrophysiology & Genetic Testing); By End User (Hospitals & Cardiac Centres, EMS & Ambulance Services, Public-Access Facilities, Schools & Workplaces, Ambulatory Centres, Home & Community Response Networks); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Cardiac Arrest Treatment Market: Defibrillator Access, Emergency Readiness, and Post-Arrest Care Shape Commercial Demand

The Global Cardiac Arrest Treatment Market is projected to grow from USD 5.23 billion in 2025 to USD 7.86 billion by 2032, expanding at a CAGR of 6... Read More

Published Date: JUL-2026 | No Of Pages:181 | $ 4485

Coagulation Factor Deficiency Market By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease); By Treatment Modality (Factor Replacement Therapy, Gene Therapy, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Coagulation Factor Deficiency Market is projected to grow at a 7.5% CAGR, rising from USD 11.5 billion in 2024 to USD 17.5 billion by 2030, driven by adva... Read More

Published Date: NOV-2025 | No Of Pages:193 | $ 4485

Bleeding Disorders Treatment Market By Product Type (Coagulation Factors, Gene Therapies, Others); By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others); By End-User (Hospitals, Specialized Treatment Centers, CROs, Home Care Providers); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bleeding Disorders Treatment Market is projected to grow from USD 10.8 billion in 2024 to USD 14.9 billion by 2030, registering a CAGR of 5.6%, driven by ... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Hemophilia Gene Therapy Market By Type of Hemophilia (Hemophilia A, Hemophilia B); By Therapy Approach (AAV-Based Gene Therapy, CRISPR and Gene Editing); By Treatment Stage (Preclinical, Clinical, Commercialized); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemophilia Gene Therapy Market is valued at USD 4.1 billion in 2024 and is expected to reach USD 16.5 billion by 2030, growing at a strong 25.6% CAGR, sup... Read More

Published Date: NOV-2025 | No Of Pages:159 | $ 4485

Mantle Cell Lymphoma (MCL) Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation, Combination Therapy); By End-User (Hospitals & Clinics, Research Institutions, CROs, Academic & Community Oncology Practices); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Mantle Cell Lymphoma (MCL) Treatment Market is projected to grow from USD 5.3 billion in 2024 to USD 7.9 billion by 2030, at a robust 6.5% CAGR, driven by... Read More

Published Date: NOV-2025 | No Of Pages:168 | $ 4485

Pelvic Congestion Syndrome Treatment Market By Treatment Type (Ovarian and Pelvic Vein Embolization, Venous Stenting, Pharmacological and Conservative Management, Surgical Treatments); By Product Type (Embolic Coils, Vascular Plugs, Sclerosants and Liquid Embolics, Catheters, Guidewires, and Access Sheaths, Contrast Agents and Other Procedure Consumables); By End User (Hospital Outpatient Interventional Radiology Departments, Specialty Vascular and Interventional Radiology Centers, Ambulatory Surgery Centers, Gynecology and Chronic Pelvic Pain Clinics); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Pelvic Congestion Syndrome Treatment Market: Embolization-Led Care, Reimbursement Barriers, and Expanding Clinical Evidence

The Global Pelvic Congestion Syndrome Treatment Market was valued at USD 1.47 billion in 2025 and is projected to reach USD 2.75 billion by 2032... Read More

Published Date: JUL-2026 | No Of Pages:164 | $ 4485

Cardiac Resynchronization Therapy Market By Product Type (CRT-P, CRT-D); By Application (Heart Failure with Reduced Ejection Fraction, Atrial Fibrillation, Post-Myocardial Infarction); By End User (Hospitals, Ambulatory Surgical Centers, Cardiologists & Clinics, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Cardiac Resynchronization Therapy Market: CRT Demand Moves Toward Upgrade Procedures, Leadless Pacing and Physiologic Resynchronization (Last Updated on: June-2026)

The Global Cardiac Resynchronization Therapy (CRT) Market is set to grow from USD 9.1 billion in 2... Read More

Published Date: NOV-2025 | No Of Pages:198 | $ 4485

Stroke Rehabilitation Market By Rehabilitation Method (Physical Therapy, Occupational Therapy, Speech Therapy, Neurostimulation); By Product Type (Therapeutic Devices, Wearable Technology, Therapeutic Software, Others); By End-User (Hospitals and Rehabilitation Centers, Home Care Settings, CROs, Forensic and Environmental Labs); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Stroke Rehabilitation Market is set to witness substantial growth, projected to expand with a robust CAGR of 7.6% , valued at approximately $24.5 billion in 2024Read More

Published Date: NOV-2025 | No Of Pages:157 | $ 4485

Spinal Stenosis Market By Treatment Type (Surgical, Non-Surgical); By Type of Stenosis (Lumbar, Cervical, Thoracic); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spinal Stenosis Market will expand at a compelling CAGR of 7.1% , valued at $7.4 billion in 2024 , and is projected to reach around $11.9 billion by 2030 ... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Human Chorionic Gonadotropin (hCG) Market By Product Type (Injectables, Oral, Test Kits); By Application (Fertility Treatments, Weight Management, Pregnancy Testing); By End User (Fertility Clinics, Pharmaceutical Companies, Diagnostic Laboratories, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Human Chorionic Gonadotropin (hCG) Market is projected to witness notable growth from 2024 to 2030, rising from USD 5.4 billion in 2024 to USD 8.74 billion by 2030 with a ... Read More

Published Date: NOV-2025 | No Of Pages:152 | $ 4485

Therapeutic Apheresis Market By Procedure Type (Plasmapheresis, Leukapheresis, Plateletpheresis, Erythrocytapheresis); By Application (Autoimmune Diseases, Neurological Disorders, Hematologic Disorders, Renal Disorders); By End User (Hospitals, Ambulatory Surgical Centers, Blood Donation Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Therapeutic Apheresis Market is set to expand at a solid CAGR of 7.3%, valued at USD 3.2 billion in 2024 and projected to reach USD 5.3 billion by 2030, d... Read More

Published Date: NOV-2025 | No Of Pages:185 | $ 4485

Nerve Repair Market By Product Type (Nerve Grafts, Neurostimulation Devices, Stem Cell Therapies, Nerve Conduits, Others); By Application (Traumatic Nerve Injury, Neurodegenerative Diseases, Diabetic Neuropathy, Others); By End-User (Hospitals, Neurology Clinics, Research Institutes, CROs, Others); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nerve Repair Market is set to grow at a CAGR of 8.6%, reaching USD 19.5 billion by 2030, up from USD 12.5 billion in 2024, according to Strategic ... Read More

Published Date: NOV-2025 | No Of Pages:190 | $ 4485

Gene Therapy Market By Vector Type (Viral Vectors [AAV, Lentivirus, Retrovirus], Non-Viral Vectors [Lipid Nanoparticles, Plasmids]); By Indication (Monogenic Disorders, Oncology, Ophthalmology, Neurology); By Delivery Method (In Vivo, Ex Vivo); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gene Therapy Market will witness a robust CAGR of 22.3%, valued at $12.4 billion in 2024, expected to appreciate and rea... Read More

Published Date: NOV-2025 | No Of Pages:198 | $ 4485

Viscosupplementation Market By Product Type (Single Injection, Multiple Injection, Combination Products); By End User (Orthopedic Clinics, Hospitals, Physiotherapy Centers); By Application (Knee Osteoarthritis, Hip Osteoarthritis, Other Joint Applications); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Viscosupplementation Market will experience steady growth from 2024 to 2030, driven by rising demand for minimally invasive treatments, osteoarthritis therapy, hya... Read More

Published Date: NOV-2025 | No Of Pages:171 | $ 4485